| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |